CLDI:NYSEMKT, Calidi Biotherapeutics, Inc.

CLDI stock overview

Calidi Biotherapeutics, Inc. (CLDI:NYSEMKT) closed at $0.478 on November 20, 2026, down 5.45% on the day. The stock trades 98.1% below its 52-week high of $24.80 and 2.6% above its 52-week low of $0.465. Over the past year, it lost 97.8%. Calidi Biotherapeutics, Inc. is part of the Funds & Shells sector.

Key figures

Price
$0.478
Day change
-5.45%
Volume
47,777
Average volume
100,242
Market cap
1M+
52-week range
$0.465 – $24.80
50-day average
$0.877
200-day average
$3.35

Price action over the past year

In 252 trading sessions since November 20, 2025, CLDI closed higher on 87 days (35%). Its best day was November 3, 2026 (+13.83%) and its worst was March 6, 2026 (-53.12%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

CLDI news

About Calidi Biotherapeutics, Inc.

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.

Similar stocks

Find more stocks like CLDI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.